Update on botulinum toxin and dermal fillers

被引:12
作者
Berbos, Zachary J. [2 ]
Lipham, William J. [1 ,2 ]
机构
[1] Minnesota Eye Consultants PA, Bloomington, MN 55416 USA
[2] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA
关键词
botulinum toxin; dermal fillers; facial rejuvenation; HYALURONIC-ACID FILLERS; NEUROTOXIN SEROTYPE-A; DOUBLE-BLIND; GLABELLAR LINES; FACIAL REJUVENATION; COMPLEXING PROTEINS; COMBINATION THERAPY; PARALLEL-GROUP; FORMULATIONS; BTX-A;
D O I
10.1097/ICU.0b013e32833ce7bc
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review The art and science of facial rejuvenation is an ever-evolving field of medicine, as evidenced by the continual development of new surgical and nonsurgical treatment modalities. Over the past 10 years, the use of botulinum toxin and dermal fillers for aesthetic purposes has risen sharply. Herein, we discuss properties of several commonly used injectable products and provide basic instruction for their use toward the goal of achieving facial rejuvenation. Recent findings The demand for nonsurgical injection-based facial rejuvenation products has risen enormously in recent years. Used independently or concurrently, botulinum toxin and dermal filler agents offer an affordable, minimally invasive approach to facial rejuvenation. Summary Botulinum toxin and dermal fillers can be used to diminish facial rhytides, restore facial volume, and sculpt facial contours, thereby achieving an aesthetically pleasing, youthful facial appearance.
引用
收藏
页码:387 / 395
页数:9
相关论文
共 70 条
[1]   Sterility assessment of multiple use botulinum A exotoxin vials: A prospective simulation [J].
Alam, Murad ;
Yoo, Simon S. ;
Wrone, David A. ;
White, Lucile E. ;
Kim, John Y. S. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (02) :272-275
[2]  
Aoki K. Roger, 2005, International Ophthalmology Clinics, V45, P25, DOI 10.1097/01.iio.0000167167.10402.74
[3]   Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions [J].
Aoki, KR ;
Guyer, B .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :21-29
[4]   A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice [J].
Aoki, KR .
TOXICON, 2001, 39 (12) :1815-1820
[5]   A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines [J].
Ascher, B ;
Zakine, B ;
Kestemont, P ;
Baspeyras, M ;
Bougara, A ;
Santini, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) :223-233
[6]  
Ascher Benjamin, 2005, Aesthet Surg J, V25, P365, DOI 10.1016/j.asj.2005.05.004
[7]  
Badarny S, 2008, ISR MED ASSOC J, V10, P520
[8]   Hyaluronic Acid Fillers: A Comprehensive Review [J].
Beasley, Karen L. ;
Weiss, Margaret A. ;
Weiss, Robert A. .
FACIAL PLASTIC SURGERY, 2009, 25 (02) :86-94
[9]   Hyaluronic acids [J].
Born, Trevor .
CLINICS IN PLASTIC SURGERY, 2006, 33 (04) :525-+
[10]   Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement [J].
Brody, HJ .
DERMATOLOGIC SURGERY, 2005, 31 (08) :893-897